OWCP OTC
OWC Pharmaceutical Research Corp.
1W: +900.0%
1M: +0.0%
3M: +900.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$7K
+12.5% ▲
Operating Income
-$4M
+5.7% ▲
Net Income
-$10M
-125.0% ▼
EPS (Diluted)
$-0.07
-120.7% ▼
EBITDA
-$4M
+21.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $50K | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | -100.0% | +0.0% |
| Cost of Revenue | $0 | $9K | $10K | $8K | $7K |
| Gross Profit | $0 | -$9K | $40K | -$8K | -$7K |
| Gross Margin | — | — | 80.6% | — | — |
| R&D Expenses | $160K | $271K | $142K | $441K | $712K |
| SG&A Expenses | $5M | $1M | $2M | $4M | $3M |
| Operating Expenses | $5M | $2M | $2M | $5M | $4M |
| Operating Income | -$5M | -$2M | -$2M | -$5M | -$4M |
| Operating Margin | — | — | -4196.1% | — | — |
| Interest Expense | $3K | $491 | $0 | $0 | $3K |
| Income Before Tax | -$5M | -$2M | -$2M | -$5M | -$10M |
| Tax Expense | $3K | $491 | $0 | $0 | $3K |
| Net Income | -$5M | -$2M | -$2M | -$5M | -$10M |
| Net Margin | — | — | -4574.7% | — | — |
| EPS (Diluted) | $-0.10 | $-0.02 | $-0.02 | $-0.03 | $-0.07 |
| EBITDA | -$5M | -$2M | -$2M | -$5M | -$4M |
| Shares Outstanding | 52M | 81M | 96M | 145M | 148M |